Revelation Biosciences Inc. [REVB] Director makes an insider acquire of 20,000 shares worth 32,000.

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Revelation Biosciences Inc. shares valued at $32,000 were purchased by TIDMARSH GEORGE F on Feb 25. At $1.60 per share, TIDMARSH GEORGE F acquired 20,000 shares. The insider’s holdings grew to 467,156 shares worth approximately $0.24 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Analyzing REVB’s Price Performance

On Thursday, Revelation Biosciences Inc. [NASDAQ: REVB] rose 1.82% to $0.51. The stock’s lowest price that day was $0.4919, but it reached a high of $0.534 in the same session. During the last five days, there has been a drop of approximately -15.09%. Over the course of the year, Revelation Biosciences Inc. shares have dropped approximately -95.01%. Shares of the company reached a 52-week high of $11.2900 on 01/05/22 and a 52-week low of $0.4036 on 06/01/22. A 50-day SMA is recorded $0.7072, while a 200-day SMA reached $3.9545. Nevertheless, trading volume fell to 1.32 million shares from 1.63 million shares the previous day.

Support And Resistance Levels for Revelation Biosciences Inc. (REVB)

According to the 24-hour chart, there is a support level at 0.4893, which, if violated, would cause prices to drop to 0.4696. In the upper region, resistance lies at 0.5314. The next price resistance is at 0.5538. RSI (Relative Strength Index) is 41.18 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2066, which suggests the price will decrease in the coming days. Percent R is at 95.69%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is Revelation Biosciences Inc. subject to short interest?

Stocks of Revelation Biosciences Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.13 million shares to 0.27 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 0.14 million shares. A jump of 46.68% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.03 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.03.

Which companies own the most shares of Revelation Biosciences Inc. (REVB)?

According to Monashee Investment Management LL filings, the company currently owns 817,562 shares, which is about 5.42% of the total REVB shares outstanding. In its current portfolio, Mayflower Financial Advisors LLC holds 21,425 shares valued at $23782.0.

In terms of Revelation Biosciences Inc. share price expectations, FactSet research, analysts set an average price target of $9.00 in the next 12 months, up nearly 1700.0% from the previous closing price of $0.50. Analysts anticipate Revelation Biosciences Inc. stock to reach $9.00 by 2022, with the lowest price target being $9.00. In spite of this, 1 analysts ranked Revelation Biosciences Inc. stock as a Buy at the end of 2022.


Please enter your comment!
Please enter your name here